Establishing the Collaborative Care Model of Traditional Chinese Medicine and Western Medicine-Pediatric Atopic Dermatitis

Atopic Dermatitis Clinical Trial

Official title:

Establishing the Collaborative Care Model of TCM and Western Medicine-Pediatric Atopic Dermatitis

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03375970
• Other study ID #: CMUH106-REC2-029
• Status: Recruiting
• Phase: N/A
• First received: May 26, 2017
• Last updated: December 15, 2017
• Start date: May 2, 2017
• Est. completion date: December 2017

Study information

• Verified date: April 2017
• Source: China Medical University Hospital
• Contact: Hung-Rong Yen
• Phone: +886975681439
• Email: hungrongyen[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

In Taiwan, there are many patients suffer from pediatric atopic dermatitis. Because of the clinical characteristic of repetitive and scratchy, which will affect the patients' quality of life and lead to the medical heavy budget. TCM may play an important role in this disease and help patient to improved their health. In this project, we aim to establish a Collaborative Care Model of TCM and Western Medicine, to achieve the multiple goal in clinical treatment, research and medical training. By establishing a collaborative care model, including the Chinese medicine doctor and Western medicine doctor, nurses, pharmacists and case managers, to cooperative satisfy the patient needed in the medical service, to improve the clinical presentation, patients'quality of life, and reduce exposure to corticosteroid. Besides, we can also build a training environment and reduce medical cost in long term purpose. Furthermore, by establishing a collaborative care model, we can provide a medical education and training opportunity to educate the medical student and clinician the necessary knowledge of pediatric atopic dermatitis by caring patients and learning from clinical case. According to the above training program, we not only aim to strengthen the competitiveness of Chinese medicine doctor in Taiwan, but also make the Western medicine doctors comprehend the TCM characteristic and may find out the even more opportunity to cooperate in clinical practice. To make this collaborative care model as a beginning milestone of cooperation between Chinese medicine and Western medicine.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 30
• Est. completion date: December 2017
• Est. primary completion date: December 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A to 18 Years

Eligibility

Inclusion Criteria:

• age 0-18

• meets the Hanifin and Rajka diagnostic criteria

• SCORAD score ? 25

Exclusion Criteria:

• Drug abuse

• Pregnent or lactating women

• Mental or behavioral abnormalities

• Allergic to the ingredients of the test regimen

• Any potentially life-threatening disease or dysfunctional organ system l

Related Conditions & MeSH terms

• Atopic Dermatitis
• Dermatitis
• Dermatitis, Atopic
• Eczema

Intervention

Other:
• TCM
oral chinese herb, chinese topical ointment
• Western medicine
oral steroid, oral antihistamine, topical steroid

Locations

Country	Name	City	State
Taiwan	China Medical University Hospital	Taichung

Sponsors (1)

Lead Sponsor	Collaborator
China Medical University Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Scoring Atopic Dermatitis (SCORAD) score	a clinical tool to assess the extent and severity of eczema	week 4
Secondary	36-Item Short Form Health Survey (SF-36)	It is a 36-item, patient-reported survey of patient health.	week 4